Innate Pharma (IPHA) Operating Margin (2005 - 2026)
Innate Pharma (IPHA) operating margin from Jun 30, 2005 to Mar 31, 2026. The current Innate Pharma (IPHA) operating margin is 1352.66%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Innate Pharma (IPHA)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -1914.70% | +368.56% |
| 2024 | -408.64% | +1573.90% |
| 2023 | -24.41% | -75.48% |
| 2022 | -99.57% | -74.79% |
| 2021 | -394.88% | -25610.00% |
| 2020 | 1.55% | -103.95% |
| 2019 | -39.22% | -708.40% |
| 2018 | 6.45% | -105.26% |
| 2017 | -122.53% | -1008.99% |
| 2016 | 13.48% | -122.42% |
| 2015 | -60.13% | -97.26% |
| 2014 | -2194.51% | +9708.42% |
| 2013 | -22.37% | -31.49% |
| 2012 | -32.66% | -49.35% |
| 2011 | -64.48% | -79.65% |
| 2010 | -316.90% | +57.53% |
| 2009 | -201.17% | +136.06% |
| 2008 | -85.22% | +33.97% |
| 2007 | -63.61% | -45.53% |
| 2006 | -116.77% | N/A |
Comparison Innate Pharma (IPHA) operating margin with competitors
Innate Pharma (IPHA) operating margin is 1352.66%.